RxDoctor Payments Data

George Johnston, DO

Interventional Pain Medicine · Medford, ORNPI 1891757464

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (34.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 60.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $7,002 and has fallen 91.7% since, to $578 in 2025.

$13,884in general payments, 2019–2025

Across 340 payments — averaging $40.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Vertiflex, Inc.$2K
  • Abbott$839
  • Relievant Medsystems, Inc.$819
  • MML US, Inc.$254
  • Daiichi Sankyo Inc.$252
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$4,60033%
  • Travel & lodging$4,04029%
  • Food & beverage$4,79335%
  • Education$4513%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,884 in reported general payments places this provider in the 80th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$122,227
Medicare patients
408
Services billed
1,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$440
Methadone Hcl11$261
Oxycodone Hcl14$226
Pregabalin14$163
Pramipexole DihydrochloridePramipexole Di-Hcl13$60
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$55

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Medford

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →